In breast cancer, lower pre‐treatment plasma PAI‐1 level was an independent prognostic factor for PFS and OS,29 and plasma PAI‐1 level did not correlate with PAI‐1 immunostaining intensity.30 This evidence concerns the gene SERPINE1 and breast cancer.